Skip to content

What Is MedDO and IvDO in Switzerland?


5 mins


MedDO Switzerland refers to Medical Device Ordinance requirements, while IvDO Switzerland represents In Vitro Diagnostic Medical Devices Ordinance requirements under Swiss regulatory oversight. Both serve as specialized regulatory frameworks that help manufacturers comply with Swiss medical device regulations administered by Swissmedic. These frameworks play important roles in facilitating market access and ensuring ongoing regulatory compliance for medical devices and IVD products in Switzerland’s healthcare market.

What Exactly Are MedDO and IvDO in the Swiss Regulatory System?

The Medical Devices Ordinance (MedDO) and the In Vitro Diagnostic Medical Devices Ordinance (IvDO) are Swiss regulatory ordinances established under national law to govern medical devices and in vitro diagnostic medical devices. These ordinances create distinct regulatory pathways:

  • MedDO Switzerland – Focuses specifically on traditional medical devices, ranging from simple instruments to complex implantable systems, with requirements for quality management systems and post-market surveillance
  • IvDO Switzerland – Specializes in in vitro diagnostic products, including laboratory tests, diagnostic kits, and related equipment, applying targeted expertise for the technical complexity of diagnostic devices
  • Swissmedic oversight – Both ordinances operate under Swissmedic authority, requiring all economic operators to demonstrate competency in Swiss regulatory requirements
  • Local expertise requirements – Particularly relevant for manufacturers needing regulatory knowledge without establishing full regulatory presence in Switzerland

These ordinances define the comprehensive legal framework within which manufacturers, authorized representatives, importers, and distributors must operate. They ensure products meet safety and performance standards while helping stakeholders understand Swiss regulatory expectations and maintain ongoing compliance in Switzerland’s healthcare market.

How Do MedDO and IvDO Requirements Differ From EU MDR and IVDR Compliance?

The Swiss MedDO and IvDO regulations maintain close alignment with EU principles while incorporating Switzerland-specific elements that create distinct compliance pathways:

  • Independent regulatory framework – Operates under Swissmedic authority rather than EU oversight, creating separate approval processes and administrative requirements
  • Additional documentation requirements – Swiss compliance often requires supplementary procedures beyond EU standards, including Swiss-specific registration processes and language requirements
  • Different implementation timelines – Swiss schedules may vary from EU timelines, particularly for transitional arrangements and grandfathering provisions
  • Direct Swissmedic communication – Emphasizes ongoing dialog with regulatory authorities, requiring understanding of Swiss administrative procedures and cultural expectations
  • Swiss-specific representation – May require Swiss Authorized Representatives (CH-REP) rather than European representatives, involving partners familiar with MedDO or IvDO frameworks

These differences create both opportunities for more tailored guidance and challenges in navigating dual compliance requirements. Manufacturers must understand how Swiss post-market surveillance obligations integrate with EU systems while maintaining separate reporting structures for each regulatory jurisdiction.

What Are the Specific Compliance Obligations for Companies Working Under MedDO and IvDO?

Companies operating under MedDO and IvDO must fulfill comprehensive compliance obligations across multiple operational areas:

  • Quality management systems – Establish ISO 13485-compliant systems with documented procedures for design controls, risk management, and corrective actions tailored to Swiss expectations
  • Registration documentation – Provide comprehensive technical files including device descriptions, clinical evidence, and risk assessments in Swiss-acceptable formats and languages
  • Post-market surveillance – Implement incident reporting systems, field safety corrective actions, and periodic safety updates according to Swissmedic timelines
  • Labeling compliance – Meet Swiss language requirements with specific safety warnings, contraindications, and instructions for use
  • Traceability systems – Maintain product identification throughout distribution chains for routine oversight and emergency response
  • Responsible person designation – Appoint qualified individuals with authority to ensure ongoing Swiss regulatory compliance

These obligations create an integrated compliance framework that supports both routine operations and emergency response capabilities. Success requires establishing robust systems early in the market entry process and maintaining them through ongoing regulatory monitoring and updates.

How Do You Navigate the MedDO and IvDO Registration Process in Switzerland?

The Swiss registration process requires systematic planning and execution across multiple phases:

  • Classification determination – Establish appropriate device classification under Swiss regulations to determine specific requirements, documentation needs, and review timelines
  • Documentation preparation – Assemble comprehensive technical files including specifications, clinical data, and quality system evidence, allowing 3-6 months for preparation and translation
  • Swissmedic submission – Complete administrative requirements with proper forms, fees, and supporting documentation for 2-6 month review periods
  • Communication management – Maintain open dialog with regulatory authorities, responding promptly to requests for additional information or clarification
  • Challenge mitigation – Address common pitfalls including inadequate documentation, insufficient clinical evidence, and incomplete post-market surveillance planning

Successful navigation requires engaging experienced regulatory professionals early in the process and conducting thorough gap analyses before submission. This systematic approach helps prevent delays while demonstrating strong commitment to Swiss regulatory compliance and facilitating smooth market entry.

How MedEnvoy Global Helps With Swiss MedDO and IvDO Compliance

MedEnvoy Global provides comprehensive regulatory consulting services specifically tailored to Swiss medical device and IVD market requirements. Our expertise spans both MedDO and IvDO compliance frameworks, helping manufacturers navigate Switzerland’s unique regulatory landscape efficiently and effectively. Our services include:

  • Strategic regulatory planning and gap analysis – Comprehensive assessment for Swiss market entry with tailored compliance roadmaps
  • Technical documentation preparation and review – Expert support for Swissmedic submissions with Swiss-specific formatting and requirements
  • Quality management system development – Implementation support for ISO 13485-compliant systems meeting Swiss expectations
  • Post-market surveillance systems – Establishment and ongoing maintenance of Swiss reporting and monitoring requirements
  • Swiss Authorized Representative services – Complete regulatory representation and ongoing compliance support
  • Translation and labeling compliance – Swiss-specific language requirements and regulatory formatting
  • Ongoing regulatory support – Continuous compliance monitoring and regulatory updates

Our experienced team combines deep knowledge of Swiss regulatory requirements with practical implementation expertise, ensuring successful market access while maintaining robust compliance systems. We provide end-to-end support from initial planning through ongoing operations, helping manufacturers achieve their Swiss market objectives efficiently and cost-effectively.

Whether you’re establishing initial MedDO or IvDO compliance or seeking ongoing regulatory support for your Swiss operations, our comprehensive approach addresses all aspects of Swiss regulatory requirements. Contact MedEnvoy Global today to learn how we can streamline your Swiss regulatory strategy and accelerate your market entry timeline.

Related Articles